<<

1282JClin Pathol 1997;50:128-134 Childhood non-Hodgkin in the

United Kingdom: findings from the UK J Clin Pathol: first published as 10.1136/jcp.50.2.128 on 1 February 1997. Downloaded from Children's Study Group

Dennis Wright, Patricia McKeever, Richard Carter

Abstract these different categories of non-Hodgkin Aim-To review the presenting clinical is distinctive. features and the histology of cases of non- (C Clin Pathol 1997;50:128-134) (NHL) entered into the United Kingdom Children's Cancer Keywords: childhood non-Hodgkin lymphoma; ; lymphoblastic lymphoma; anaplastic large Study Group NHL Trial. cell lymphoma. Methods-Sections of biopsy specimens from all cases entered into the trial were stained with Giemsa and haematoxylin Non-Hodgkin lymphomas represent 4-6% of and eosin. All cases were stained inumuno- all malignant neoplastic of childhood.' histochemically for CD45, CD3, CD45RO, About 85% of children in the United Kingdom CD20, and CD30. Sections were stained with non-Hodgkin lymphomas are enrolled in with either naphthol AS-D chloroacetate the NHL trials organised by the United King- esterase or KP1 (CD68) to identify granu- dom Children's Cancer Study Group (UK- locytic tumours. In a minority of cases, CCSG), amounting to approximately 80 new additional immunohistochemical stains cases each year. The original diagnostic biopsy were performed when necessary to estab- specimens from these children were examined lish the diagnosis. The sections were by a separate review panel and, in this report, reviewed by three pathologists. the panel's findings are presented for nearly Results-Of 308 cases analysed, 293 were 300 cases. Paediatric non-Hodgkin lymphomas categorised as NHL. There was only one differ from the adult disease, in that they are case of low grade lymphoma in the series. almost all high grade, have a diffuse growth Over 80% of the cases fell into the catego- pattern and commonly involve extranodal sites. our cases one ries Burkitt lymphoma lympho- The majority of fell into of three http://jcp.bmj.com/ (42.2%), diagnostic groups: Burkitt lymphoma, lym- blastic lymphoma (27.2%) and anaplastic phoblastic lymphoma and anaplastic large cell large cell lymphoma (15.1%). Cases of lymphoma. Treatment regimes for these three Burkitt lymphoma presented most often categories differ,' and as they are rapidly with abdominal tumours mainly of the progressive tumours, optimum management ileocaecal region. Tumours of the requires both prompt and accurate histological oropharynx and nasopharynx were also

diagnosis. on October 1, 2021 by guest. Protected copyright. University common in this group. Of the 84 lympho- Department of blastic lymphomas, 56 were of the T-cell Pathology, Level E, phenotype, 12 of the B-cell phenotype and Methods South Block, 16 of indeterminate lineage. Most of the Ten unstained paraffin wax sections and a copy Southampton General of the pathology report were requested for all Hospital, Tremona T-lymphoblastic lymphomas showed me- diastinal or involvement. Infiltra- patients entered into the UKCCSG NHL Road, Southampton pleural trials. In exceptional cases, a tissue block was S016 6YD tion ofthe skin and soft tissues was seen in D H Wright submitted and occasionally the panel chairman 25% of lymphoblastic lymphoma of B or obtained additional sections. Many of the indeterminate phenotype. Forty six chil- Department of biopsy specimens had already been referred to Pathology, Clinical dren were diagnosed as having anaplastic a paediatric pathologist at the treatment centre Sciences Building, large cell lymphoma, the majority being of for review and the results of the investigations Leicester Royal T or indeterminate lineage. Most patients done at the referral laboratory were usually Infirmary, PO Box 65, presented with lymphadenopathy but in- available. All sections were stained with Leicester LE2 7LX volvement ofthe bones, soft tissues or skin P McKeever haematoxylin and eosin and with Giemsa stain. was seen in seven patients and of the Immunohistochemistry, using either the Children's mediastinum and lungs in five. APAAP or the immunoperoxidase method, was Department, Royal Conclusion-Childhood non-Hodgkin lym- performed routinely with CD45, the lineage Marsden Hospital, phomas are almost all high grade and markers CD3 and CD20, and with CD45RO Sutton, frequently extranodal. They fall mainly Surrey SM2 SPT (UCHL1) and CD30. In the early part of the R Carter into the categories Burkitt lymphoma, lym- study, one section was routinely stained for phoblastic lymphoma and anaplastic large naphthol AS-D chloroacetate esterase to iden- Correspondence to: cell lymphoma. The separation of these tify granulocytic tumours. This was later Professor D H Wright. subcategories can be made on the basis of replaced by immunohistochemical staining for Accepted for publication morphology and immunohistochemical CD68 (KP1). Sections in individual cases were 8 November 1996 features. The anatomical distribution of also stained with directed against Childhood non-Hodgkin lymphomas in the United Kingdom 129

Table 1 UKCCSG NHL trials: overall summary ofpanel diagnoses and sex distribution directed against muramidase, bcl-2 and the of the cases Ki-67 antigen. The sections were then circulated among the Diagnosis Number (0,) Male Female three members of the review panel who J Clin Pathol: first published as 10.1136/jcp.50.2.128 on 1 February 1997. Downloaded from Burkitt lymphoma 130 (42.2) 110 20 categorised them independently using the Kiel Lymphoblastic 84 (27.2) 57 27 T 56; indeterminate 16; B 12 classification. The panel came together, on a Large cell anaplastic 46 (15.0) 29 17 few occasions, to review those cases in which Indeterminate 22; T16; ?T6; B2 there was disagreement and to reach a consen- Centroblastic/Centroblastic centrocytic 10 (3.3) 6 4 Other B-lineage lymphomas 14 (4.5) 9 5 sus opinion. B-high grade (NOS) 12'; primary mediastinal large B-cell lymphoma 1; T-cell-rich B-cell Results lymphoma 1 Other T-lineage lymphomas 4 (1.3) 2 2 Of 308 cases analysed by the panel, 293 were Peripheral T3; T-high-grade (NOS) lb categorised as non-Hodgkin lymphoma (table Histiocytic 1 (0.3) - 1 1). In 11 cases, the sections were considered to Non-Hodgkin lymphoma (NOS)' 4 (1.3) 2 2 Reactive/no evidence of lymphoma/inadequate 11 (3.6) 6 5 be inadequate for diagnosis or to show no evi- material dence of lymphoma. No diagnosis was made in No diagnosis made 4 (1.3) 3 1 four cases. There was only one case of low Total 308 (100) 224 84 grade lymphoma in the series. This was a folli- 'Ten of the 12 cases incompletely classified because of poor quality material. cle centre cell lymphoma, centroblastic/ bIncompletely classified because of poor quality material. centrocytic follicular, presenting as lymphad- cTwo of the four cases incompletely classified because of poor quality material. enopathy in a 14 year old boy. Two cases of epithelial membrane antigen (EMA), S- 100 centroblastic lymphoma, follicular and diffuse, and, in a few instances, with antibodies and seven cases categorised as centroblastic, diffuse would fall into the intermediate grade of the . Twelve biopsy specimens designated B-cell, high grade NOS, because the quality of the histological prepara- tions did not permit a more exact diagnosis, were probably Burkitt lymphomas. Almost 90% of the cases, therefore, fell within the cat- egories of Burkitt lymphoma, lymphoblastic lymphoma and anaplastic large cell lymphoma.

BURNTT LYMPHOMAS Burkitt lymphomas showed a monomorphic proliferation of blast cells with rounded nuclei and granular nuclear chromatin. The cells contained one to four nucleoli which were identifiable but rarely prominent. Tumours http://jcp.bmj.com/ always showed a high mitotic index and large numbers of apoptotic cells and nuclear frag- ments. The latter were often engulfed by mac- rophages that gave the tumour a characteristic starry sky appearance (fig 1). Burkitt lymphoma cells had a well-defined, but narrow, Figure 1 Low power view ofBurkitt lymphoma showing sheets of monomorphic lymphoid on October 1, 2021 by guest. Protected copyright. cells interspersed with large, clear containing apoptotic debris, giving the rim of deeply basophilic cytoplasm, best seen characteristic starry sky pattern (original magnification x80). in Giemsa stained sections and usually best visualised at the edge of the section (fig 2). Small vacuoles corresponding to lipid droplets were seen within this rim of cytoplasm in many cases (fig 2). The tumour cells were positive for CD45 and CD20 and negative for T-lineage markers and CD30.

LYMPHOBLASTIC LYMPHOMAS Lymphoblastic lymphomas also showed a monomorphic proliferation of blast cells with round, oval or convoluted nuclear outlines. The nuclear chromatin was fine and dispersed with two to four small nucleoli. Tumours showed a high mitotic index with frequent apoptotic cells. A starry sky pattern with vacu- olated macrophages was occasionally seen but was rarely as prominent as in Burkitt lymphoma (fig 3). The cytoplasm of these cells was inconspicuous and showed weak to moderate basophilia in the Giemsa stain in Figure 2 Burkitt lymphoma showing monomorphic blast cells with granular nuclear contrast to Burkitt lymphoma cells (fig 4). chromatin and one or more, usually inconspicuous, nucleoli. The cytoplasm of these cells is well-defined, amphophylic and contains small, lipid vacuoles (original magnification Most lymphoblastic lymphomas were positive x800). for CD45 but 13 examples did not stain; nine 130 Wright, McKeever, Carter

' CD3, and B-lineage tumours by the expression of CD20. Tumours expressing neither CD3

;.t %;i21 ;W? nor CD20 were categorised as being of J Clin Pathol: first published as 10.1136/jcp.50.2.128 on 1 February 1997. Downloaded from indeterminate lineage. '4

ANAPLASTIC LARGE CELL LYMPHOMA 1ES<;Me xt, * Anaplastic large cell lymphomas were com- posed of large cells with pleomorphic, horse- .. * .... shoe shaped (embryo-like) nuclei. In some - ^ instances, multiple nuclei occurred in a wreath- ; like pattern and sometimes gave rise to cells resembling Reed-Sternberg cells (although in no instance did the panel have difficulty in separating anaplastic large cell lymphoma from Hodgkin disease). Tumour cells with more monomorphic rounded nuclei also frequently occurred, either as the predominant population or mixed with the more pleomorphic variants (fig 5). Anaplastic large cell lymphoma cells Figure 3 Lymphoblastic lymphoma showing a diffuse infiltrate ofblast cells replacing most had more abundant cytoplasm than other lym- ofthe lymph node structure, apartfrom one residual germinal centre. Theere are scattered phomas, although the staining quality of this clear histiocytes, giving a starry sky pattern less noticeable than that seen zin Burkitt lymphoma (original magnification x80). cytoplasm was variable. In biopsy specimens where the lymph node architecture was par- tially retained, the tumour cells characteristi- cally grew within the sinuses. In a few cases, they showed a very notable perivascular distri- %...... bution. In some examples, the tumour was accompanied by an intense infiltrate of inflam- matory cells which, on occasions, masked the neoplastic cells. All cases diagnosed as anaplas- i tic large cell lymphoma showed expression of CD30 (BERH2) on the tumour cell membrane and in the Golgi region (fig 6). It highlighted the tumour cells and frequently accentuated their cohesive nature. Expression of CD45 was variable, with no staining observed in 18 cases. A 4 Cases in which the tumour cells expressed

CD3 were categorised as being of the T-cell http://jcp.bmj.com/ #4El .e, tumour cells & phenotype. In two cases, the ..Z': 49 ww. expressed CD20 in the absence of T-lineage .- o a^f.. markers and were classified as being of the X- '. B-cell lineage. Cases not expressing CD3 or Figure 4 Lymphoblastic lymphoma showing blast cells with fine nuclear chromatin and CD20 were categorised as being of indetermi- one or more nucleoli. Mitotic figures are frequent. The cytoplasm is ill-dejfined and pale nate lineage. In 22 biopsy specimens, the staining (original magnification x800). tumour cells expressed EMA, although stain- on October 1, 2021 by guest. Protected copyright. ing was sometimes weak, focal, and present in X only a few of the neoplastic cells. A single case was diagnosed as a histiocytic sarcoma on the basis of negative staining for B- and T-cell lineage markers with positive * reactivity for CD68 and muramidase. This * * <4$* tumour occurred as a pelvic mass in a three _ year old girl. The case of follicle centre cell lymphoma, centroblastic/centrocytic and the nine cases of centroblastic lymphoma (follicu-

lar or diffuse) were diagnosed using standard morphological criteria; all of them expressed C4D45 and CD20. A mediastinal tumour from * a 15 year old girl was diagnosed as a primary mediastinal (thymic) large B-cell lymphoma. A cervical lymph node biopsy specimen from a

,> .t *~~~~ seven year old boy was diagnosed as a * e Ji T-cell-rich B-cell lymphoma, on the basis of its * * morphology and phenotype. Four biopsy specimens were categorised as peripheral T-cell Figure 5 Anaplastic large cell lymphoma. In this tumour, the neoplasti cellshave rengular, lymphomas, as distinct from anaplastic large oval nuclei, usually with a single nucleolus. The cytoplasm of these cell is abundant and eosinophilic (original magnification x320). cell lymphoma. All of them were negative for CD30. of these were of T-lineage. I1-llymphoblastic The main anatomical sites of disease for the lymphomas were identified by tlhe expression of three major groups of childhood non-Hodgkin Childhood non-Hodgkin lymphomas in the United Kingdom 131

AA Eighty four (27.2%) cases were diagnosed as lymphoblastic lymphoma. Of these, 56 were T-cell, 12 B-cell and 16 of indeterminate lineage. Thirty two (38% of the whole series) J Clin Pathol: first published as 10.1136/jcp.50.2.128 on 1 February 1997. Downloaded from presented with peripheral lymphadenopathy. Infiltration of the skin and soft tissues was observed in 25% ofpatients with lymphoblastic lymphomas of B and indeterminate lineages. Twenty seven (32%) of the 56 T-lymphoblastic lymphomas showed involvement of the medi- astinum or pleura, a localisation not seen in .s;, lymphoblastic lymphomas of B-cell or indeter- minate subtypes. Forty six (15%) cases were diagnosed as anaplastic large cell lymphoma. About 70% * presented with peripheral lymphadenopathy, *8>b«,, but several other sites were also involved. Seven patients presented with lymphoma in bones, Z~~~~~~~~ soft tissue or skin, and five with disease in the Figure 6 Anaplastic large cell lymphoma stained to show CD30. Mote the strong mediastinum or lungs. membrane and Golgi staining. Many of the tumour cells in this neoj have irregular plasm In the whole there were 224 males and nuclei or appear multinucleated (APAAP; original magnification x.320). series, 84 females, giving a male to female sex ratio of lymphomas are shown in talble 2. One hundred 2.7:1 (table 3). The male to female sex ratio of and thirty (42.2%) cases vvere categorised as Burkitt lymphoma was 5.5:1, whereas for lym- Burkitt lymphoma (table I L). Eighty eight of phoblastic lymphomas it was 2.1:1 and for these 130 patients presente-d with abdominal anaplastic large cell lymphoma 1.5:1. Of the tumours. These were often extensive and their 293 cases, 288 fell within the age range of one exact location was not recc)rded. In 37 cases, to 15 years (table 3). There was only one the tumour was noted to irivolve the terminal patient under the age of one year and four over or ileocaecal regiora. Three tumours the age of 16, although the small number of involved the stomach and four were localised to patients in the latter category was due to the the . Seventeen patients presented with selection criteria for the trial. The patients tumours in Waldeyer's ririg. Nine of these seem to be roughly equally spread over the age involved the oropharynx or tonsil and eight the range from one to 15 years, although Burkitt nasopharynx. Only 13 of th e 130 patients pre- lymphoma is slightly more common in the sented with peripheral lymphadenopathy. middle, lymphoblastic lymphoma in the first, Twelve cases designated Ihigh grade, B-cell and anaplastic large cell lymphoma in the last were lymphoma, NOS prc)bably poorly pre- quinquennium. http://jcp.bmj.com/ served Burkitt lymphomais with a similar After an initial settling in period, the review anatomical distribution to the cases diagnosed panel achieved a concordance rate of over 90% as Burkitt lymphoma. Witth the addition of on first review. This is, perhaps, not surprising, these cases, Burkitt lymph(oma would consti- as 90% of the patients fell within three catego- tute 46% of the whole serie,s. ries that differed, not only in their morphology

Table 2 UKCCSG NHL trials: principal anatomical sites ofdiseasefor the three major histological subtypes on October 1, 2021 by guest. Protected copyright.

Lymphoblastic Burkitt lymphoma Indeterminate Anaplastic large cell Anatomical site (n 130) T(n= 56) (n 16) B (n 12) (n= 46) Peripheral lymph nodes 13 21 5 6 32 Abdominal/pelvic massa 40 - 1 - - Ileum, ileocaecal region 37 - - Mediastinum, pleurab - 27 3 Oropharynx, tonsil 9 1 - 1 Skin, soft tissue - 3 4 3 5 Bone 7 1 - - 2 Nasopharynx, nasal cavity 8 1 Salivary glands 2 1 2 - 1 Brainc 1 1 2 Bone marrow 2 - 1 2 Liver 3 Testis - 2 1 1 ' 4 Stomach 3 Duodenum, pancreas 1 - - - 1 Lungs - - - - 2 Oral cavity' Total 130 56 (+2)' 16 12 (+2)' 46 'Includes biopsy specimens of mesentery, mesenteric nodes, omentum, and an umbilical nodule. 'Includes biopsy specimens of mediastinal nodes, thymic region, and pericardium. cIncludes one mass in cerebellopontine angle. dOnly includes specified ovarian masses. Other examples are likely to be classified under abdominal/pelvic mass. 'Soft tissues, distinct from jaws. 'Two biopsy specimens from two different sites, submitted from two patients. gTwo biopsy specimens from two different sites, submitted from two patients. 132 Wright, McKeever, Carter

Table 3 UKCCSG NHL trials: distribution ofdiagnoses by age expressed. Staining for terminal deoxynucleoti- dyl transferase, which has recently been Age (years) reported in paraffin wax embedded tissue J Clin Pathol: first published as 10.1136/jcp.50.2.128 on 1 February 1997. Downloaded from Diagnosis <1 1-5 6-10 11-15 >16 sections,4 would also provide a marker for pre-

Burkitt lymphoma (n = 130) - 38 50 41 1 cursor B- or T-cell lymphomas (lymphoblastic Lymphoblastic (n = 84) 1 34 25 24 lymphomas). Large cell anaplastic (n = 4) - 9 13 23 1 The only major area of disagreement be- Centroblastic - 2 2 6 Centroblastic/centrocytic tween the panel diagnosis and that of the refer- (n = 10) ring pathologists was of Burkitt lymphoma Other B-lineage (n = 14) - 2 6 5 1 which was originally described as B-lym- Peripheral T, Other T-lineage - 2 1 - 1 (n = 4) phoblastic lymphoma in 35 cases. This dis- Histocytic (n = 1) - 1 cordance, however, relates more to the use of Non-Hodgkin lymphoma - 1 1 2 (NOS) (n = 4) terminology than to histological interpretation. Reactive/no evidence of - 3 4 4 - Burkitt lymphoma was categorised as a lymphoma seen (n = 1 1) B-lymphoblastic lymphoma in the first version No diagnosis made (n = 4) - 2 1 1 Total 1 94 103 106 4 of the Kiel classification,5 an error that was subsequently rectified in the updated version of this classification.6 In the FAB classification of but also in their immunophenotype. There was lymphoblastic leukaemia, cases of Burkitt also a high level of agreement between the lymphoma with extensive bone marrow in- panel diagnoses and those of the referring volvement and overspill into the peripheral pathologists. Two referred diagnoses of non- blood are still referred to as acute Hodgkin lymphoma, single examples ofT-non- lymphoblas- Hodgkin tic lymphoma (ALL-L3).7 Lymphoblastic lym- lymphoma NOS and anaplastic large phomas arise from early or progenitor B and were lymphoma, eventually rejected by the cells, whereas Burkitt lymphoma cells show panel as non-neoplastic. One referred diagno- features of more mature B cells in their expres- sis of anaplastic large cell lymphoma was sion of lineage markers and surface immu- re-classified as Hodgkin disease. No examples of non-lymphomatous, round cell tumours, noglobulin. The molecular genetics of Burkitt mis-diagnosed as non-Hodgkin lymphoma, lymphoma and B-lymphoblastic lymphoma are were encountered. The largest area ofdisagree- different, as are their immunophenotype and ment would seem to be amongst the Burkitt morphology.8 There is a need for classification lymphomas, 35 ofwhich were diagnosed by the systems to make a clear distinction between referring pathologist as B-lymphoblastic lym- these separate . phomas (see discussion). Many of the other Burkitt lymphoma is the commonest subtype discrepancies between the submitted and the of childhood non-Hodgkin lymphoma in the panel diagnoses were minor and related to the UK. By definition, this is categorised as or immunophenotype assignment or were of a sporadic non-endemic Burkitt lymphoma. http://jcp.bmj.com/ semantic nature. Endemic and non-endemic Burkitt lymphoma are morphologically indistinguishable,9 prob- Discussion ably because both groups of tumours have This study gave us an unprecedented translocations between the c- gene and one opportunity to examine and categorise a large of the immunoglobulin genes, leading to c-myc series of unselected non-Hodgkin lymphomas deregulation.'0 Deregulated c-myc results in

in children. It does, however, have a number of cells that continuously replicate but do not dif- on October 1, 2021 by guest. Protected copyright. limitations. The amount of clinical information ferentiate and, therefore, show little morpho- available to us was usually small and it was logical variation. Despite their morphological sometimes necessary to obtain more details identity, endemic and sporadic Burkitt from the paediatricians. The anatomical sites of lymphoma differ in their molecular genetics, in disease, listed in table 2, represent the major that the breakpoints in relation to the c-myc areas of involvement and also, in children with and immunoglobulin genes are usually multifocal disease, the regions which were most different."1-13 In addition, endemic Burkitt accessible for biopsy. The diagnostic material lymphoma is always associated with Epstein- submitted to the panel was usually restricted to Barr , whereas only one third of non- 10 paraffin wax sections, with little opportunity endemic cases carry the virus.'4 The two to undertake detailed immunophenotypic tumours also differ in their clinico-anatomical analysis in difficult cases. When setting up our features. Endemic Burkitt lymphoma has a sex study in 1990, we selected L26 (CD20) as the ratio of 2.1 males to one female,'5 whereas in best available B-lineage marker at that time.2 this series the ratio was 5.5:1. Non-endemic L26 does, however, have limitations, especially Burkitt lymphoma presents most frequently for a study of childhood lymphomas, as it does with abdominal and pelvic tumours, often not stain very early B cells. In contrast, CD79a involving the ileocaecal region. The orophar- is expressed on B cells at the time when immu- ynx and nasopharynx are the second most noglobulin is first synthesised.3 If we had used common tumour sites. This anatomical distri- this , throughout the study, we should bution would be uncommon in endemic probably have detected more B-lymphoblastic Burkitt lymphoma in which abdominal tu- lymphomas which may not express CD20. mours are usually retroperitoneal and tumours This problem does not apply to Burkitt of Waldeyer's ring are rare.'6 Peripheral lym- lymphoma which represents a later stage of phadenopathy is almost never seen in endemic B-cell development at which CD20 is always Burkitt lymphoma, whereas it was a presenting Childhood non-Hodgkin lymphomas in the United Kingdom 133

feature in 10% of the cases of non-endemic plasm. The abundant cytoplasm of the tumour Burkitt lymphoma in this series. cells, their cohesive growth pattern and ten- The clinical and anatomical differences dency to infiltrate the sinuses of lymph nodes between endemic and sporadic Burkitt may lead to a diagnosis of metastatic tumour, J Clin Pathol: first published as 10.1136/jcp.50.2.128 on 1 February 1997. Downloaded from lymphoma have been recorded previously."7 If particularly undifferentiated carcinoma or Burkitt lymphoma had not been defined on the amelanotic melanoma. The frequent expres- basis of its microscopic features which, as sion of EMA24 25 by the tumour cells and, in stated above, are probably directly related to rare instances, cytokeratins,26 27 together with c-myc deregulation, the sporadic disease would the failure ofsome cases to express CD4527 28 or not have been labelled as Burkitt lymphoma. lineage markers, may compound this error. The semantic confusion surrounding these Some cases induce an intense histiocytic reac- tumours has been further complicated by the tion that may obscure the tumour cells.29 30 The use of the terms "Burkitt-like" or "small entity anaplastic large cell lymphoma, non-cleaved cell non-Burkitt". When applied Hodgkin-like,8 may be impossible to differenti- to childhood lymphomas, the distinction be- ate from Hodgkin disease, but no such cases tween Burkitt and non-Burkitt lymphomas occurred in this series. The chromosomal seems to lack clinical importance and may be translocation (2;5)(p23;q35) occurs in about because of minor morphological variation or 30-40% of cases of anaplastic large cell histological artefact.1' Morphological, pheno- lymphoma and seems to be more common in typic and clinical differences have emerged childhood than adult cases.3'-34 The (2;5) when this distinction is applied to lymphomas translocation results in the fusion of the at all ages, with Burkitt lymphomas predomi- nucleophosmin gene on chromosome 5q35 to nating in children and Burkitt-like lymphomas a novel tyrosine kinase encoding gene desig- in adults.'9 2 These Burkitt-like lymphomas do nated anaplastic lymphoma kinase on chromo- not show the rearrangements of the c-myc and some 2p2335 and in the production of an immunoglobulin genes that characterise abnormal fusion protein.36 The deregulated Burkitt lymphoma.2" It is our opinion that the tyrosine kinase activity of this fusion protein designation Burkitt-like, as a single diagnostic may be important in the pathogenesis of term, should be avoided and that, at the present anaplastic large cell lymphoma. Antibodies to time, such cases should be designated high this fusion protein have been shown to stain grade B-cell lymphomas, Burkitt-like, as rec- both the nucleus and cytoplasm oftumour cells ommended in the REAL classification.8 Stain- in about 30% of cases of anaplastic large cell ing sections with the proliferation marker lymphoma, mainly those occurring in child- MIB1 (Ki-67) is used by one of the authors hood and having a good .36 It seems, (DHW) as an aid to the identification of therefore, that most cases of anaplastic large Burkitt lymphoma. All Burkitt lymphomas cell lymphoma in adults have a different patho- show c-myc deregulation and, thus, have 100% genesis from those occurring in childhood. It is labelling index ofthe tumour cells. This level of yet to be determined how homogeneous the labelling is rarely seen in other lymphomas. childhood cases in our series are. Five cases http://jcp.bmj.com/ The majority of the lymphoblastic lympho- showed t(2;5) by conventional cytogenetics. mas were of the T-cell phenotype. Mediastinal Patients with congenital tumours were common in this group and in 27 syndromes are at increased risk of developing patients this was the site of biopsy, although, in non-Hodgkin lymphomas. There were two 21 patients, enlarged cervical or supraclavicu- children with ataxia telangiectasia in this series. lar lymph nodes provided a more accessible One developed high grade non-Hodgkin biopsy site. The use of an antibody directed lymphoma of indeterminate lineage, involving on October 1, 2021 by guest. Protected copyright. against CD79a would probably have identified the brain and cervical lymph nodes, at the age a B-cell lineage for some of the cases of of three years. The other patient developed an indeterminate phenotype.3 Involvement of the anaplastic large cell lymphoma of B-phenotype skin and soft tissues, which is said to be a char- involving an axillary lymph node at the age of acteristic of B- and pre-B-lymphoblastic 10. lymphomas,2'-23 was seen in 25% of the B-cell and indeterminate group but in only 5% of the We are indebted to the many consultant pathologists who T-lymphoblastic lymphomas. Although bone forwarded their diagnostic material on which this study is based. We thank Ms Elizabeth Philp and her stafffor technical help and marrow infiltration was observed in three cases Julie Foster for typing the manuscript. The latter part of the of lymphoblastic lymphoma, this constituted work was funded by grants made to the UKCCSG by the less than 25% ofthe cells at which level the case Department of Health. would have been designated as lymphoblastic 1 Sandlund JT, Downing JR, Crist WM. Non-Hodgkin's leukaemia and not entered into the non- lymphoma in childhood. N Engl3Med 1996;334:1238-48. Hodgkin lymphoma trial. 2 Norton AJ, Isaacson PG. Detailed phenotypic analysis of B-cell lymphoma using a panel of antibodies reactive in Primary anaplastic large cell lymphoma is routinely fixed, wax embedded tissue. Am J Pathol the third commonest childhood non-Hodgkin 1987;128:225-40. 3 Mason DY, Cordell JL, Tse AJD, van Dongen JJM, van lymphoma in this series. These patients were Noesel CJM, Micklem K, et al. The IgM associated protein generally older than the children with Burkitt mb-i as a marker of normal and neoplastic B-cells. J Immunol 1991;147:2474-82. lymphoma and lymphoblastic lymphoma, and 4 Orazi A, Cotton J, Cattoretti G, Kotylo PK, John K. most presented with cervical lymphadenopa- Manning JT, Neiman RS. Terminal deoxynucleotidyl transferase staining in acute and normal bone thy. Skin, soft tissues and bone were the marrow in routinely processed paraffin sections. Am J Clin presenting sites in seven patients and the medi- Pathol 1994;102:640-5. 5 Gerard-Marchant R, Hamblin I, Lennert K, Rilke F, Stans- astinum in three. Pathologists will be aware of feld AG, van Unnik JAM. Classification of non-Hodgkin's the diagnostic pitfalls associated with this neo- lymphomas. Lancet 1974;ii:406. 134 Wright, McKeever, Carter

6 Stansfeld AG, Diebold J, Noel H, Kapanci Y, Rilke F, Kel- 23 Cossman J, Chused TM, Fisher RI, Magrath I, Bollum F, enyi G, et al. Updated Kiel classification for lymphomas. Jaffe ES. Diversity of immunological phenotypes of Lancet 1988;i:292-3. lymphoblastic lymphoma. Cancer Res 1983;43:4486-90.

7 Bennett JM, Catovsky D, Flandrin G, Galton DAG, Graln- 24 Delsol G, Al Saati T, Gatter KC, Gerdes J, Schwarting RE, J Clin Pathol: first published as 10.1136/jcp.50.2.128 on 1 February 1997. Downloaded from ick HR, Sultan C. Proposals for the classification of the Caveriviere P, et al. Co-expression of epithelial membrane acute leukaemias. Brj Haematol 1976;33:451-8. antigen (EMA), Ki-1 and interleukin-2 receptor by 8 Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary anaplastic large cell lymphomas. Diagnostic value in ML, et al. A revised European-American classification of so-called malignant histiocytosis. Am J Pathol 1988;130: lymphoid neoplasms: A proposal from the International 59-70. Lymphoma Study Group. Blood 1994;84:1361-92. 25 Fujimoto J, Hata J, Ishii E, Kiyokawa N, Tanaka S, 9 Berard C, O'Conor GT, Thomas LB, Torloni H. His- Morikawa Y, et al. Ki-l lymphoma in childhood: Immuno- topathological definition of Burkitt's tumour. Bull World histochemical analysis and the significance of epithelial Health Organ 1969;40:601-7. membrane antigen (EMA) as a new marker. Virchows Arch 10 Knowell PC, Croce CM. Chromosome translocations and [A] 1988;412:307-14. in human lymphoid tumors. Am _7 Clin Pathol 26 Frierson HF, Belafiore FJ, Gaffey MJ, McCary WS, Innes 1990;94:229-37. DJ, Williams ME. Cytokeratin in anaplastic large cell 11 Gutierrez M, Bahitia K, Barraga R, Diez B, Sackmann MF, lymphoma. Mod Pathol 1994;7:317-21. de Andreas M. Molecular epidemiology of Burkitt's 27 Gustmann C, Altmannsberger M, Osborn M, Griesser H, lymphoma from South America: Differences in breakpoint Feller AC. Cytokeratin expression and vimentin content in locations and EBV association from tumors in other world large cell anaplastic lymphomas and other non-Hodgkin's regions. Blood 1992;79:3261 -6. lymphomas. AmnjPathol 1991;138:1413-22. 12 Pilicci P, Knowles D, Magrath I, Dalla-Favera R. Chromo- somal breakpoints and structural alterations ofthe C-MYC 28 Falini B, Pileri S, Stein H, Dieneman D, Dallenbach F, Del- locus differ in endemic and sporadic forms of Burkitt sol G, et al. Variable expression of leucocyte common lymphoma. Proc Natl Acad Sci USA 1986;83:2984-90. (CD45) antigen in CD30 (Ki-1) positive anaplastic large 13 Neri A, Barriga F, Knowles D, Magrath I, Dalla-Favera R. cell lymphoma: Implications for the differential diagnosis Different regions of the immunoglobulin heavy-chain locus between lymphoid and non-lymphoid malignancies. Humn are involved in chromosomal translocations in distinct Pathol 1990;21:624-9. pathogenetic forms of Burkitt lymphoma. Proc Natl Acad 29 Pileri S, Falini B, Delsol G, Stein H, Baglioni P, Poggi S, et Sci USA 1988;85:2748-54. al. Lymphohistocytic T-cell lymphoma (anaplastic large 14 Magrath IT. The pathogenesis of Burkitt's lymphoma. In: cell lymphoma CD30+/Ki-1 + with a high content of reac- Van de Woued GF, Klein G, eds. Advances in cancer tive histiocytes). Histopathology 1990;16:383-91. research. San Diego: Academic Press, 1990:133-270. 30 Pileri S, Sabattini E, Poggi IS, Amini M, Falini B, Stein H. 15 Burkitt DP. General features and facial tumours. In: Burkitt Lymphohistiocytic T-cell lymphoma [letter]. Histopathology, DP, Wright DH, eds. Burkitt's lymphoma. Edinburgh and 1994;25:191-3. London: E and S Livingstone, 1970:6-15. 31 Rimokh R, Magaud J-P, Berger F, Samarut J, Coiffier B, 16 Wright DH. Gross distribution and haematology. In: Burkitt Germain D, et al. A translocation involving a specific DP, Wright DH, eds. Burkitt's lymphoma. Edinburgh and breakpoint (q35) on is characteristic of London: E and S Livingstone, 1970:64-81. anaplastic large cell lymphoma ("Ki- 1 lymphoma"). Br _7 17 Magrath IT, Sariban E. Clinical features of Burkitt's Haenmatol 1989;71:31-6. lymphoma in the USA. In: Lenoir G, O'Conor G, Olweny 32 Le Beau MM, Bitter MA, Larson RA, Doane LA, Ellis ED, CLM, eds. Burkitt's lymphonma:A human cancer model. Lyon: Franklin WA, et al. The t(2;5)(p23;q35): Recurring IARC Scientific Publications, Number 60, 1985:119-27. chromosomal abnormality in Ki-1 positive anaplastic large 18 Hutchison RE, Murphy SB, Fairclough DL, Shuster JJ, Sul- cell lymphoma. Leukemia 1989;3:866-70. livan MP, Link MP, et al. Diffuse, small, non-cleaved cell 33 Bitter MA, Franklin WA, Larson RA, McKeithan TW, lymphoma in children. Burkitt's versus non-Burkitt's types: Rubin CM, Le Beau MM, et al. Morphology in Ki- 1 Results from the Pediatric Group and St Jude (CD30)-positive non-Hodgkin's lymphoma is correlated Children's Research Hospital. Cancer 1989;64:23-8. with clinical features in the presence of a unique 19 Payne CM, Grogan TM, Cromey DW, Bjore CG, Kerrigan chromosomal abnormality, t(2;5)(p23;q35). Anm 7 Surg DP. An ultrastructural, morphometric and immunopheno- Pathol 1990;14:305-16. typic evaluation of Burkitt's and Burkitt's-like lymphomas. 34 Mason DY, Bastard C, Rimokh R, Dastugue N, Huret J-L, Lab Invest 1987;57:200-18. Kristoffersson U, et al. CD30-positive large cell lymphomas 20 Yano T, van Krieken JHJM, Magrath IT, Longo DL, Jaffe ("Ki-I lymphoma") are associated with a chromosomal ES, Raffeld M. Histogenetic correlations between sub- translocation involving 5q35. BrJ Haematol 1990;74:161- categories of small, non-cleaved cell lymphomas. Blood 8. 1992;79:1282-90. 35 Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Sha- 21 Bernard A, Murphy SB, Melvin S, Bowman P, Caillaud J, piro DN, Saltman DL, Look AT. Fusion of a kinase gene http://jcp.bmj.com/ Lemerle J, et al. Non-T, non-B lymphomas are rare in (ALK), to a nucleolar protein gene, NPM, in non- childhood and associated with cutaneous tumor. Blood Hodgkin's lymphoma. Science 1994;263:1281-6. 1982;59:549-54. 36 Shiota M, Nakamura S, Ichinohasama R, Abe M, Akagi T, 22 Link MP, Roper M, Dorfman RF, Crist WM, Cooper MD, Takeshita M, et al. Anaplastic large cell lymphomas Levy R. Cutaneous lymphoblastic lymphoma with pre-B expressing the novel chimeric protein p80N'M'"AL A distinct markers. Blood 1983;61:838-41. clinico-pathologic entity. Blood 1995;86: 1954-60. on October 1, 2021 by guest. Protected copyright.